Treatment of respiratory distress syndrome in preterm infants

Phase 3

• Conditions: neonatal respiratory distress syndrome.; Respiratory distress syndrome of newborn; P22.0

• Registration Number: IRCT20151123025202N9
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 July 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 96

Inclusion Criteria

gestational age of 28-37 weeks
With distress syndrome
Fraction of inspired oxygen>40
Require treatment with surfactant in less than 24 hours after birth

Exclusion Criteria

APGAR score<5
Suffering from any congenital disease

Study & Design

• Study Type: interventional
• Study Design: Not specified